The global impact of Precision Medicine Group.
As it happens.

Impact, observations, and insights on the evolving healthcare landscape.

Webinar: Scaling Up a Gene Therapy Manufacturing Facility

2021-10-22T09:37:06-04:00Cell & Gene Therapy, Events|

Scaling up a gene therapy manufacturing facility is extremely complex and challenging. In this webinar, co-sponsored by Precision ADVANCE and Project Farma, a panel of industry experts discuss the strategies and challenges faced when building a cutting-edge gene therapy facility from the planning stages to build-out to operational readiness. They will also share key insights into their company’s approach to building these facilities and for mitigating risk under accelerated timelines.


Cowen Inc. 10th Annual MedTools Conference: Exploring the Complexities of Cell and Gene Therapy Development and Commercialization

2021-10-07T09:32:38-04:00Cell & Gene Therapy, Events|

Attending the Cowen Inc. 10th Annual MedTools Conference this week? Project Farma (PF) EVP, John Khoury will be joining a panel of industry experts to speak on “Exploring the Complexities of Cell and Gene Therapy Development and Commercialization” Thursday, October 7, 10:10 – 11:05 AM ET.


STAT Virtual Event: CAR-T comes of age?

2021-10-05T15:52:32-04:00Cell & Gene Therapy, Events|

It’s been almost a decade since the release of the first stunning data on a cell therapy that battled blood cancer by genetically altering a patient’s own white blood cells to attack it. Many years and billions of dollars in mergers and acquisitions later, CAR-T is still used mostly as a last resort. Could new clinical trials that are about to report out in full change that?


On-Demand Webinar: Pricing Strategies for Advanced Therapies

2021-10-19T15:16:07-04:00Cell & Gene Therapy, Events|

There is no doubt that the advanced therapies sector is growing at an exponential rate. According to a recently published 2021 Report by ARM (Alliance for Regenerative Medicine), the sector has raised $14.1B in financing in the first half of 2021 which is already 71% of what was raised in all of 2020. In addition, there are over 2,600 advance therapy clinical trials being conducted with 264 of those trails being Phase 3 trials and another 1,500 being Phase 2 trials.


AMCP & Precision ADVANCE Corporate Training Program

2021-09-08T08:32:34-04:00Cell & Gene Therapy, Events|

Cell and gene therapies present tremendous clinical and humanistic opportunity to change the course of disease but also present several unique aspects that differ from more traditional therapies. These differences will impact how innovators develop evidence and manufacture and distribute products. Payers also need to adapt how they assess value, make coverage decisions, and manage reimbursement.


Load More Posts